Related Experiment Video
Updated: May 12, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Mild cognitive impairment
1lopezol@upmc.edu
Purpose Of Review:
The term mild cognitive impairment (MCI) is used to describe older subjects with demonstrable cognitive impairment who have not crossed the threshold for dementia. Because patients with MCI have an increased risk of developing dementia, especially Alzheimer disease (AD), there is significant interest in the clinical characterization of these subjects and in understanding the pathophysiology of the transition from MCI to AD.
Recent Findings:
The MCI syndrome, as an expression of an incipient disorder that may lead to dementia, is extremely heterogeneous and may coexist with systemic, neurologic, or psychiatric disorders that can cause cognitive deficits. Recent clinical criteria were designed to take into account the different forms of clinical presentation of the syndrome, and introduced the possible contribution of biomarkers to the clinical diagnosis. Bedside diagnosis of MCI can be difficult, since patients who report having cognitive problems may have normal scores in global cognitive scales or in brief neuropsychological instruments.
Summary:
This article presents the evolution of the clinical concept of MCI, the operationalization of its current definitions, the development of biomarkers that can help to identify an underlying neurodegenerative process as the etiology of the syndrome, and its proposed treatments.
Insights
Mild cognitive impairment (MCI) describes cognitive deficits in older adults at high risk for dementia. Understanding MCI
Area of Science:
- Neurology
- Geriatrics
- Cognitive Science
Background:
- Mild cognitive impairment (MCI) signifies cognitive deficits in older adults preceding dementia.
- MCI patients face an elevated risk of developing dementia, particularly Alzheimer's disease (AD).
- Understanding the transition from MCI to AD is crucial for early intervention.
Purpose of the Study:
- To review the evolving clinical concept of MCI.
- To discuss the operationalization of current MCI definitions.
- To explore biomarkers and treatments for MCI.
Main Methods:
- Review of clinical criteria for MCI diagnosis.
- Incorporation of biomarker contributions to diagnosis.
- Assessment of challenges in bedside MCI diagnosis.
Main Results:
- MCI is a heterogeneous syndrome, potentially coexisting with other disorders.
- Recent criteria address diverse clinical presentations and biomarker use.
- Accurate bedside diagnosis can be challenging due to normal cognitive scale scores.
Conclusions:
- The article traces the clinical evolution and definitions of MCI.
- Biomarker development aids in identifying neurodegenerative causes.
- Proposed treatments for MCI are discussed.
More Related Videos
Related Concept Videos
Dementia l: Introduction
Cognitive Development During Adulthood
Intellectual Disability
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Dementia
The progression of dementia is generally gradual.

